semaglutide compound ending The FDA is drawing a harder line on compounded weight loss drug marketing. In the May–June 2026 issue of Dispense Times, this article breaks down key violations cited in recent FDA enforcement FDA ends semaglutide shortage, closing

Who microdosing may benefit People who experience intolerable side effects even at the lowest standard dose may benefit from starting even lower

semaglutide is currently recommended by NICE only within specialist Tier 3 weight management services for a maximum of two years

If your provider switches your prescription from one to the other, your injection protocol does not need to change

But is it a whole new therapeutic target for DKD

The molecule was rationally designed by Eli Lilly scientists to simultaneously engage three G-protein-coupled receptors central to metabolic homeostasis: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor

The Electric Power Research Institute projects that data centers will consume 17% of US electricity by 2030